rs762412447
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM2PM5PP3_ModeratePP5
The NM_000232.5(SGCB):c.355A>T(p.Ile119Phe) variant causes a missense change. The variant allele was found at a frequency of 0.00000684 in 1,461,582 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I119N) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000232.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SGCB | NM_000232.5 | c.355A>T | p.Ile119Phe | missense_variant | 3/6 | ENST00000381431.10 | |
SGCB | XM_047416074.1 | c.145A>T | p.Ile49Phe | missense_variant | 2/5 | ||
SGCB | XM_047416075.1 | c.58A>T | p.Ile20Phe | missense_variant | 2/5 | ||
SGCB | XM_047416076.1 | c.58A>T | p.Ile20Phe | missense_variant | 2/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SGCB | ENST00000381431.10 | c.355A>T | p.Ile119Phe | missense_variant | 3/6 | 1 | NM_000232.5 | P1 | |
SGCB | ENST00000506357.5 | c.*137A>T | 3_prime_UTR_variant, NMD_transcript_variant | 4/5 | 5 | ||||
SGCB | ENST00000514133.1 | c.*150A>T | 3_prime_UTR_variant, NMD_transcript_variant | 3/4 | 5 |
Frequencies
GnomAD3 genomes ? Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251470Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135904
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461582Hom.: 0 Cov.: 30 AF XY: 0.0000124 AC XY: 9AN XY: 727110
GnomAD4 genome ? Cov.: 32
ClinVar
Submissions by phenotype
Autosomal recessive limb-girdle muscular dystrophy type 2E Pathogenic:2Uncertain:4
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 24, 2022 | - - |
Likely pathogenic, flagged submission | clinical testing | Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics | - | A heterozygous missense variation in exon 3 of the SGCB gene that results in the amino acid substitution of Phenylalanine for Isoleucine at codon 119 was detected.This variant has not been reported in the 1000 genomes and gnomAD databases. The in silico predictions of the variant are possibly damaging by PolyPhen-2 (HumDiv) and damaging by SIFT, LRT and by MutationTaster2. The reference codon is conserved across species. In summary, the variant meets our criteria to be classified as likely pathogenic. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Aug 10, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces isoleucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 119 of the SGCB protein (p.Ile119Phe). This variant is present in population databases (rs762412447, gnomAD 0.01%). This missense change has been observed in individual(s) with clinical features of limb-girdle muscular dystrophy (PMID: 9565988, 27671536, 34925456, 35416532). ClinVar contains an entry for this variant (Variation ID: 282249). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SGCB protein function. This variant disrupts the p.Ile119 amino acid residue in SGCB. Other variant(s) that disrupt this residue have been observed in individuals with SGCB-related conditions (PMID: 29970176), which suggests that this may be a clinically significant amino acid residue. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Jun 01, 2017 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Oct 10, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | - | The missense variant c.355A>T (p.Ile119Phe) in SGCB gene has been reported in individual(s) affected with muscular dystrophy (Monies D et.al.,2016) . This variant has been reported to the ClinVar database as Uncertain Significance. The p.Ile119Phe variant is novel (not in any individuals) in 1000 Genomes and allele frequency of 0.00001988% is reported in gnomAD. The amino acid Ile at position 119 is changed to a Phe changing protein sequence and it might alter its composition and physico-chemical properties. The amino acid change p.Ile119Phe in SGCB is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Uncertain Significance. - |
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 08, 2021 | Not observed at significant frequency in large population cohorts (Lek et al., 2016); Missense variants in this gene are often considered pathogenic (Stenson et al., 2014); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 9565988, 8968749, 30564623, 27671536) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 12, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at